This slide kit presents data from recent clinical trials, including ExTRACT-TIMI (Enoxaparin and Thrombolysis Reperfusion for Acute Myocardial Infarction Treatment-Thrombolysis in Myocardial Infarction) 25 and other studies, on the use of antithrombotic therapy in high risk ST elevation myocardial infarction (STEMI) patients. Patient populations assessed include those with advanced age, diabetes, or reduced renal function, as well as in those undergoing percutaneous coronary intervention. This slide kit includes evidence on the benefit of reducing the dosage of antithrombotic agents in high-risk patients.

This CME slide kit focuses on educating physicians on the importance of preventing venous thromboembolism (VTE) in acutely ill medical patients, including those with acute ischemic stroke (AIS). The goal of the program is to improve physician understanding of the type and incidence of complications following AIS; the use of heparin, low-molecular-weight heparin, and heparinoids in the prevention of VTE; and the effects of small sample sizes and methodologic limitations when measuring risk and comparing the results of clinical trials in this patient population.

This slide kit provides information on the use of fibrinolytic therapy in the management of pulmonary embolism (PE). Dr Russell Hull describes the results of studies of fibrinolytic therapy in patients with massive or submassive PE.